Special Issue "Stem Cells and Regenerative Medicine"
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (30 April 2017)
Dr. Ilyas Singeç
Director, Stem Cell Translation Laboratory (SCTL), NIH Regenerative Medicine Program, National Center for Advancing Translational Sciences (NCATS), 9800 Medical Center Drive, Rockville, MD 20892, USA
Website | E-Mail
Interests: cell reprogramming; iPS cells; cell differentiation; quantitative biology; high-throughput screening; cell therapy; tissue engineering; neurological and psychiatric diseases; personalized medicine
The discovery of induced pluripotent stem cells (iPSCs) over a decade ago has transformed stem cell biology and biomedical research. The promise of the iPSC technology holds tremendous potential for disease modeling, drug discovery, predictive toxicology, and regenerative medicine applications. As progress is being made, there is strong interest in addressing the immediate translational challenges and knowledge gaps in order to bring iPSC-based therapeutics closer to patients. In particular, comprehensive approaches and tangible solutions are needed for establishing and disseminating quality control standards for safety, reproducibility, and scalable cell differentiation. Careful molecular studies ranging from epigenetic, genetic, proteomic, and metabolic analyses are of importance in order to better understand iPSC biology in comparison to embryonic stem cells and other cell types. This Special Issue will focus on basic and translational iPSC research for improved characterization and elucidation of patient- and disease-specific cells during pluripotency, differentiation, and application in vitro and in vivo.
Dr. Ilyas Singeç
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- iPS cell
- embryonic stem cells
- cell differentiation
- molecular characterization
- disease modeling
- cell replacement
- drug screening
- cell maturation